2010

ERCC-1 Protein Expression and Its Correlation with Survival Rate in Patients with Advanced Non-small Cell Lung Cancer Receiving Cisplatin/Carboplatin-based Chemotherapy: a Retrospective study

Naritchaya Phattana, M.D.

การศึกษาการใช้ยาซิทูซิแมบ (Cetuximab) ในผู้ป่วยมะเร็งลาไส้ใหญ่ระยะแพร่กระจายที่มีผลการตรวจ K-ras mutation เป็น wild type ในโรงพยาบาลศิริราช

ศรัณย์ กิจศรัณย์ พบ. และ ณรงค์ กีรติวิทยานันท์ พบ.

Prevalance of K-RAS Genemutation in Pancreatic Cancer in Thai Patients

Wittawat Jitpewngarm, M.D. and Virote Sriuranpong, M.D.

Quality of Life of Old and New chemotherapy regimen in Advanced Non Small Cell Lung Cancer

จิรเจษฎ์ สุขสุเพิ่ม พบ. และ เจษฎา มณีชวขจร พบ.

RRM1 and ERCC1 protein expression in Cholangiocarcinoma: 5 Years Retrospective Study in Division of Medical Oncology, Maharaj Nakorn Chiang Mai Hospital

Thatthan Suksombooncharoen, M.D., Nirush Lertprasertsuke, M.D. and Sumitra Thongprasert, M.D.

Characteristics and Outcome of Early-onset Breast Cancer Patients at Siriraj Hospital

Siriwimon Saichamchan, M.D., Akarin Nimmannit, M.D. and Charuwan Akewanlop, M.D.

Role of HER2 overexpression as a prognostic factor in T1 breast cancer, Ramathibodi Experience

Luangyot Thongthieang, M.D., Touch Ativitavas, M.D., Sunsanee Wongwaisayawan, M.D., Nintita Sripaiboonkij, M.D., Thitiya Sirisinha, M.D., Ekaphop Sirachainan, M.D., Ravat Panvivchian, M.D. and Vorachai Ratanatharathorn, M.D.

KRAS mutation patterns and clinical outcomes of Thai patients with colorectal cancer receiving cetuximab

Autkittanon P, M.D. , Sirachainan E, M.D., Reukumneuychok B, M.D., Limsuwanachot N, M.D., Ativitavas T, M.D., Sirisinha T, M.D., Panvichian R, M.D. and Ratanatharathorn V, M.D.

The Benefit of Adjuvant Chemotherapy in Resected Early Stage NON-SMALL CELL LUNG CANCER and Role of The Excisision Repair Cross Complementation Group 1 (ERCC1) Protein Expression as A Predictive Factor of Platinum-Based Adjuvant Chemotherapy, RAMATHIBODI Experience

Piyawan Tienchaiananda, M.D., Touch Ativitavas, M.D., Mana Rochanawuth, M.D., Patcharee Karnsombut, M.D. ,Thitiya Sirisinha, M.D., Ekaphop Sirachainan, M.D., Ravat Panvichian, M.D. and Vorachai Ratanatharathorn, M.D.

Survival of Early Stage Breast Cancer: Rajavithi Hospital Experience

Ki Ruikchuchit, M.D., Sudsawat Laohavinij, Ph.D. M.D., and Jedzada Maneechavakajorn, M.D.

O-Methylguanine-DNA-Methyltransferase Expression in Thai Patients with Malignant Gliomas: Outcome and Response to treatment in Ramathibodi Hospital: a Retrospective Cohort Study

Wipawee Akwattanakul, M.D., Thitiya Sirisinha, M.D., Noppadol Larbcharoensub, M.D., Sasivimol Rattanasiri, M.D., Ekaphob Sirachainan, M.D., Ravat Panvichian, M.D., Touch Ativitavas, M.D., Vorachai Ratanatharathorn, M.D.

Randomized, double-blind, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high dose cisplatin in medical practice

Kanakorn Runglodvatana, M.D., Akarin Nimmannit M.D., Apirom Laocharoenkeat, Charuwan Akewanlop,M.D., Vichien Srimuninnimit,M.D., Narong Keerativitayanan,M.D., Nopadol Soparattanapaisarn, M.D. and Suthinee Ithimakin, M.D.

Cost Analysis Between Tyrosine Kinase Inhibitor versus Docetaxel in Advanced Non-Small Cell Lung Cancer

Nuttapong Topibupong, M.D. and Virote Sriuranpong, M.D.